SEVERE ATOPIC DERMATITIS (AD)

Clinical trials for SEVERE ATOPIC DERMATITIS (AD) explained in plain language.

Never miss a new study

Get alerted when new SEVERE ATOPIC DERMATITIS (AD) trials appear

Sign up with your email to follow new studies for SEVERE ATOPIC DERMATITIS (AD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a common eczema drug help kids grow stronger?

Disease control Terminated

This study aimed to see if using the approved eczema medication dupilumab could help children with severe eczema grow better and develop stronger bones. It planned to look at children aged 6 to 12 whose eczema was not well-controlled with standard creams. The study was withdrawn …

Matched conditions: SEVERE ATOPIC DERMATITIS (AD)

Phase: PHASE4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SEVERE ATOPIC DERMATITIS (AD)

Get alerted when new SEVERE ATOPIC DERMATITIS (AD) trials appear

Could a common eczema drug help kids grow stronger?